✦ LIBER ✦

Clinical Approval Success Rates for Investigational Cancer Drugs

✍ Scribed by DiMasi, J A; Reichert, J M; Feldman, L; Malins, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risks in new drug development: Approval

✍ DiMasi, J 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 223 KB

Trends in Risks Associated With New Drug

✍ DiMasi, J A; Feldman, L; Seckler, A; Wilson, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Investigational cancer drugs targeting c

✍ Sborov, Douglas W; Haverkos, Bradley M; Harris, Pamela J 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 759 KB

New drug approval success rate in Europe

✍ Eichler, Hans-Georg; Aronsson, Bo; Abadie, Eric; Salmonson, Tomas 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 224 KB

Early Accelerated Approval for Highly Ta

✍ Chabner, Bruce A. 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 845 KB

Drug development and clinical trials—the

✍ Rubin, Eric H.; Gilliland, D. Gary 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 359 KB